☆ 4.7 Article

Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices

VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Aspirin and Infection: A Narrative Review

Stefano Di Bella et al.

Summary: Acetylsalicylic acid (ASA), derived from white willow bark, is a widely used drug known for its anti-inflammatory and platelet-inhibiting properties. However, it is also suggested to have anti-infective effects, and the clinical outcome varies depending on dosages.

BIOMEDICINES (2022)

添加到收藏夹

Article Cell Biology

The Acid Ceramidase Is a SARS-CoV-2 Host Factor

Nina Geiger et al.

Summary: The study demonstrates that fluoxetine and its derivative AKS466 can interfere with the replication of SARS-CoV-2 by inhibiting acid ceramidase activity. The findings suggest that acid ceramidase may serve as a host factor for SARS-CoV-2.

CELLS (2022)

添加到收藏夹

Article Anesthesiology

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Jonathan H. Chow et al.

Summary: A retrospective cohort study in multiple hospitals in the United States showed that aspirin use in COVID-19 patients may be associated with reduced risk of mechanical ventilation, ICU admission, and in-hospital mortality. Further studies are needed to confirm a causal relationship.

ANESTHESIA AND ANALGESIA (2021)

添加到收藏夹

Article Microbiology

The SARS-CoV-2 RNA-protein interactome in infected human cells

Nora Schmidt et al.

Summary: Characterizing the interactions between SARS-CoV-2 viral RNAs and host cell proteins during infection can enhance our understanding of viral RNA functions and the host innate immune response. Identification of specific host proteins that restrict viral replication and exploring defense strategies will aid in the development of targeted therapeutics against SARS-CoV-2.

NATURE MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19

Qiang Liu et al.

Summary: In a study involving adults infected with SARS-Cov-2, it was found that patients using low-dose aspirin (100 mg/day) had significantly lower 30-day and 60-day mortality rates compared to those not using aspirin, although there was no significant difference in viral duration between the two groups.

MEDICINE (2021)

添加到收藏夹

Review Physiology

The Manifold Roles of Sphingolipids in Viral Infections

Elita Avota et al.

Summary: Sphingolipids play essential roles in viral infections, and targeted interventions in sphingolipid metabolism may offer new possibilities for antiviral therapies. Research on the interactions between different viruses and sphingolipids is ongoing, with repurposing of existing sphingolipid metabolism inhibitors for viral infections showing promise.

FRONTIERS IN PHYSIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants

Tomiko Oskotsky et al.

Summary: This study investigated the association of SSRIs with outcomes in patients with COVID-19 using electronic health records. The results suggest that SSRIs, especially fluoxetine, may be associated with reduced mortality in COVID-19 patients. Further research and clinical trials are needed to confirm these findings.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak et al.

Summary: Research has found that Fluoxetine can effectively inhibit SARS-CoV-2 infection and show activity in human lung tissue. Both stereoisomers of Fluoxetine exhibit similar activity against the virus, with the R-form possibly being specifically used for SARS-CoV-2 treatment.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Infectious Diseases

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye H. Khoo et al.

Summary: The study found that molnupiravir is safe and well tolerated in treating early COVID-19 patients. A dose of 800mg twice daily for 5 days was recommended for Phase II evaluation.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Article Virology

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication

Benjamin E. Nilsson-Payant et al.

Summary: Research suggests that in SARS-CoV-2 infection, NF-kappa B activation plays a crucial role in viral replication in the absence of traditional IFN-I-related transcription factors. Silencing NF-kappa B transcription factors or using inhibitors can reduce virus replication. These findings contribute to a better understanding of SARS-CoV-2 replication mechanisms and provide a basis for the development of novel treatment approaches.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

Fengming Liu et al.

Summary: This study found that SARS-CoV-2 may directly infect mature vascular endothelial cells in vivo and ex vivo, potentially contributing to cardiovascular complications in SARS-CoV-2 infection, including multiple organ failure.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

添加到收藏夹

Letter Cell Biology

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Manli Wang et al.

CELL RESEARCH (2020)

添加到收藏夹

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Markus Hoffmann et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Pauline Maisonnasse et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Vanessa Neuhaus et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

添加到收藏夹

Article Infectious Diseases

Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study

Bernadette Glatthaar-Saalmueller et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)

添加到收藏夹

Article Virology

NF-κB Signaling Differentially Regulates Influenza Virus RNA Synthesis

Naveen Kumar et al.

JOURNAL OF VIROLOGY (2008)

添加到收藏夹

Article Cell Biology

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-κB-inhibiting activity

Igor Mazur et al.

CELLULAR MICROBIOLOGY (2007)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of acetylsalicylic acid on nuclear Factor-kappa B activation and on late preconditioning against infarction in the myocardium

G Jancso et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.